slack Wonder sunflower annkristin heine Decent Starting point calf
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy,Journal of Cancer Research and Clinical Oncology - X-MOL
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Immunotherapy as an advance in cancer medicine - Innovations Report
Implementing combinatorial immunotherapeutic regimens against cancer
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Researchers release the brakes on the immune | EurekAlert!
CIO Bonn - Lymphomzentrum
UKB NewsRoom | Annkristin Heine
Tumor rejection in Cblb−/− mice depends on IL-9 and Th9 cells | Journal for ImmunoTherapy of Cancer
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Bjørn Heine Strand - NIPH
Medicine®
Café Kinderwagen: ein Angebot für Groß und Klein | Spökenkieker - Ihr regionales Anzeigenmagazin
G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors